| (Values in U.S. Thousands) | Dec, 2021 | Sep, 2021 | Jun, 2021 | Mar, 2021 | Dec, 2020 |
| Sales | 440 | 180 | 460 | 24,530 | 14,280 |
| Sales Growth | +144.44% | -60.87% | -98.12% | +71.78% | -44.95% |
| Net Income | -92,870 | -43,740 | -78,530 | -32,260 | -75,530 |
| Net Income Growth | -112.32% | +44.30% | -143.43% | +57.29% | -60.46% |
Progenity Inc
(PROG)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Biora Therapeutics Inc. is a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond. Biora Therapeutics Inc., formerly known as Progenity Inc., is based in SAN DIEGO.